Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-31

Clinical Trial Update: ACEMg Hearing Preservation, Tinnitus and Hyperacusis Relief [NA]

View source ↗

Summary

This document reports a completed clinical trial evaluating ACEMg for hearing preservation as well as relief of tinnitus and hyperacusis in sensorineural hearin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACEMg (magnesium-based compound)

Snippet

Sponsor: Keep Hearing, Inc. | Conditions: Sensorineural Hearing Loss, Tinnitus | NA | Status: COMPLETED